We are live on ! Find out more
TS

Twin Securities Portfolio holdings

AUM $206M
1-Year Est. Return 77.79%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+77.79%
3 Year Est. Return
+466.97%
5 Year Est. Return
+1,667.28%
10 Year Est. Return
+13,530.48%
AUM
$206M
AUM Growth
-$55.5M
Cap. Flow
-$58.8M
Cap. Flow %
-28.52%
Top 10 Hldgs %
97.59%
Holding
26
New
9
Increased
6
Reduced
1
Closed
9

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$41.8M
2
CWAN
Clearwater Analytics
CWAN
+$26.4M
3
HOLX
Hologic
HOLX
+$7.11M
4
WBD icon
Warner Bros
WBD
+$5.18M
5
ACLX
Arcellx
ACLX
+$4.76M

Top Sells

Rank Stock Value
1
CYBR
CyberArk
CYBR
+$59.4M
2
EXAS
Exact Sciences
EXAS
+$49.1M
3
RNAM
Avidity Biosciences
RNAM
+$26.3M
4
CFLT
Confluent
CFLT
+$15.3M
5
NSC icon
Norfolk Southern
NSC
+$7.28M

Sector Composition

Rank Sector Weight
1 Communication Services 62.27%
2 Healthcare 17.56%
3 Technology 14.06%
4 Consumer Staples 4.02%
5 Industrials 0.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EA icon
1
Electronic Arts
EA
$52.4B
$91.1M 44.21%
446,948
+207,112
+86% +$41.8M
WBD icon
2
Warner Bros
WBD
$64.6B
$35.7M 17.32%
1,299,915
+184,926
+17% +$5.18M
CWAN
3
DELISTED
Clearwater Analytics
CWAN
$27.5M 13.36%
1,164,090
+1,114,776
+2,261% +$26.4M
HOLX
4
DELISTED
Hologic
HOLX
$13.5M 6.57%
179,036
+94,523
+112% +$7.11M
KVUE icon
5
Kenvue
KVUE
$37B
$8.28M 4.02%
480,517
+74,934
+18% +$1.33M
ACLX
6
DELISTED
Arcellx
ACLX
$6.2M 3.01%
+53,982
New +$4.76M
TERN
7
DELISTED
Terns Pharmaceuticals
TERN
$6.11M 2.97%
+115,958
New +$4.76M
APLS
8
DELISTED
Apellis Pharmaceuticals
APLS
$5.13M 2.49%
+127,440
New +$2.75M
RVMD icon
9
PUT
Revolution Medicines
RVMD
$40.2B
$3.79M 1.84%
+39,000
New +$3.94M
RVMD icon
10
Revolution Medicines
RVMD
$40.2B
$3.75M 1.82%
+38,593
New +$3.9M
OS
11
DELISTED
OneStream Inc
OS
$1.45M 0.7%
+60,372
New +$1.42M
TTWO icon
12
Take-Two Interactive
TTWO
$43B
$1.28M 0.62%
+6,500
New +$1.41M
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
$678K 0.33%
+31,626
New +$446K
RNA
14
Atrium Therapeutics
RNA
$197M
$667K 0.32%
+49,913
New +$701K
TIC
15
TIC Solutions Inc
TIC
$1.58B
$509K 0.25%
77,339
– –
MANU icon
16
Manchester United
MANU
$3.91B
$251K 0.12%
14,920
+350
+2% +$5.96K
SGRY icon
17
Surgery Partners
SGRY
$2.06B
$119K 0.06%
10,025
-160,233
-94% -$2.3M
CDTX
18
DELISTED
Cidara Therapeutics
CDTX
– –
-4,900
Closed -$1.08M
CFLT
19
DELISTED
Confluent
CFLT
– –
-505,486
Closed -$15.3M
CYBR
20
DELISTED
CyberArk
CYBR
– –
-133,145
Closed -$59.4M
EXAS
21
DELISTED
Exact Sciences
EXAS
– –
-483,589
Closed -$49.1M
MLYS icon
22
Mineralys Therapeutics
MLYS
$2.35B
– –
-16,737
Closed -$607K
NSC icon
23
Norfolk Southern
NSC
$78.8B
– –
-25,200
Closed -$7.28M
RNAM
24
DELISTED
Avidity Biosciences
RNAM
– –
-365,144
Closed -$26.3M
WBD icon
25
CALL
Warner Bros
WBD
$64.6B
– –
-20,100
Closed -$579K
1
2

Similar funds

ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
SC
Stance Capital Boston, Massachusetts $206M AUM 22.76% 1-Year Est. Return
LPFG
Landing Point Financial Group Avon, Ohio $206M AUM 15.97% 1-Year Est. Return
AFT
Alpha Family Trust Los Angeles, California $206M AUM 35.6% 1-Year Est. Return
SCM
SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return
SAM
Stenahm Asset Management Guernsey $206M AUM 42.47% 1-Year Est. Return
HM
Harvest Management New York $206M AUM 95.44% 1-Year Est. Return

Twin Securities's Q1 2026 Portfolio in Review

As of Q1 2026, Twin Securities held 26 positions worth $206M, down 21% from $262M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Twin Securities withdrew a net $58.8M in Q1 2026, closing 9 positions and reducing 1 holding. Its most notable exit was CyberArk, an estimated $59.4M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 62% of assets, up from 31% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Twin Securities opened a new position in Arcellx worth $6.2M.

  • Twin Securities's largest Q1 2026 buy was Arcellx: 53,982 shares worth $6.2M.
  • Twin Securities added most to Electronic Arts in Q1 2026, an estimated $41.8M increase.
  • Twin Securities's biggest Q1 2026 reduction was Surgery Partners, cutting an estimated $2.3M.
  • Twin Securities fully exited CyberArk in Q1 2026, selling an estimated $59.4M.
  • Twin Securities's ten largest holdings make up 98% of its $206M portfolio in Q1 2026.
  • Twin Securities opened 9 new positions and closed 9 in Q1 2026.
  • Twin Securities's portfolio value fell 21% quarter-over-quarter to $206M.

Based on Twin Securities's 13F filing for Q1 2026, filed 15 May 2026.